Low incidence of de novo HLA antibodies after COVID-19 vaccination: A cohort study of patients awaiting kidney transplantation.

Ahmad Abu-KhaderQian HuFareed KamarIwona GalaszkiewiczWenjie WangFaisal KhanNoureddine Berka

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2023)

In rare cases, new anti-HLA antibodies were observed after COVID-19 vaccination, with potential implications for transplantation. The low incidence of this phenomenon is outweighed by the clinical benefits of vaccination.

Keyphrases

kidney transplantation
coronavirus disease
sars cov
end stage renal disease
risk factors
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
stem cells
peritoneal dialysis
risk assessment
cell therapy
climate change
human health
patient reported